Compare TTK HEALTHCARE with AJANTA PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs AJANTA PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE AJANTA PHARMA TTK HEALTHCARE/
AJANTA PHARMA
 
P/E (TTM) x 21.7 31.8 68.3% View Chart
P/BV x 1.5 6.6 22.0% View Chart
Dividend Yield % 1.1 0.5 199.4%  

Financials

 TTK HEALTHCARE   AJANTA PHARMA
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-19
AJANTA PHARMA
Mar-19
TTK HEALTHCARE/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,2151,422 85.4%   
Low Rs610898 68.0%   
Sales per share (Unadj.) Rs444.4233.5 190.3%  
Earnings per share (Unadj.) Rs17.244.0 39.2%  
Cash flow per share (Unadj.) Rs27.652.2 53.0%  
Dividends per share (Unadj.) Rs5.009.00 55.6%  
Dividend yield (eoy) %0.50.8 70.6%  
Book value per share (Unadj.) Rs177.9255.1 69.8%  
Shares outstanding (eoy) m14.1388.02 16.1%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x2.15.0 41.3%   
Avg P/E ratio x52.926.4 200.6%  
P/CF ratio (eoy) x33.022.2 148.5%  
Price / Book Value ratio x5.14.5 112.8%  
Dividend payout %29.020.5 141.6%   
Avg Mkt Cap Rs m12,894102,081 12.6%   
No. of employees `0002.36.8 34.0%   
Total wages/salary Rs m1,3074,307 30.3%   
Avg. sales/employee Rs Th2,715.73,022.6 89.8%   
Avg. wages/employee Rs Th565.3633.4 89.3%   
Avg. net profit/employee Rs Th105.4569.1 18.5%   
INCOME DATA
Net Sales Rs m6,27920,554 30.5%  
Other income Rs m78211 36.8%   
Total revenues Rs m6,35620,765 30.6%   
Gross profit Rs m4965,664 8.7%  
Depreciation Rs m147721 20.4%   
Interest Rs m3412 291.4%   
Profit before tax Rs m3935,143 7.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1491,273 11.7%   
Profit after tax Rs m2443,870 6.3%  
Gross profit margin %7.927.6 28.6%  
Effective tax rate %37.924.8 153.2%   
Net profit margin %3.918.8 20.6%  
BALANCE SHEET DATA
Current assets Rs m2,71711,812 23.0%   
Current liabilities Rs m1,5713,776 41.6%   
Net working cap to sales %18.339.1 46.7%  
Current ratio x1.73.1 55.3%  
Inventory Days Days3277 41.6%  
Debtors Days Days4782 57.2%  
Net fixed assets Rs m99114,398 6.9%   
Share capital Rs m141175 80.6%   
"Free" reserves Rs m2,37322,277 10.7%   
Net worth Rs m2,51422,452 11.2%   
Long term debt Rs m37 51.5%   
Total assets Rs m4,15826,962 15.4%  
Interest coverage x12.6444.3 2.8%   
Debt to equity ratio x00 460.0%  
Sales to assets ratio x1.50.8 198.1%   
Return on assets %6.714.4 46.4%  
Return on equity %9.717.2 56.2%  
Return on capital %16.923.0 73.8%  
Exports to sales %3.60-   
Imports to sales %0.50-   
Exports (fob) Rs m225NA-   
Imports (cif) Rs m31NA-   
Fx inflow Rs m22510,682 2.1%   
Fx outflow Rs m712,102 3.4%   
Net fx Rs m1548,580 1.8%   
CASH FLOW
From Operations Rs m1733,748 4.6%  
From Investments Rs m97-2,228 -4.3%  
From Financial Activity Rs m-307-1,475 20.8%  
Net Cashflow Rs m-3845 -83.4%  

Share Holding

Indian Promoters % 65.4 73.8 88.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 1.6 238.7%  
FIIs % 5.2 7.6 68.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 17.0 151.8%  
Shareholders   12,723 20,968 60.7%  
Pledged promoter(s) holding % 0.0 4.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   FRESENIUS KABI ONCO.  DIVIS LABORATORIES  ALEMBIC LTD  ALKEM LABORATORIES  ELDER PHARMA  

Compare TTK HEALTHCARE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices End Flat; Power and Telecom Stocks Witness Buying(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views on News

AJANTA PHARMA Announces Quarterly Results (4QFY20); Net Profit Up 45.3% (Quarterly Result Update)

May 21, 2020 | Updated on May 21, 2020

For the quarter ended March 2020, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 45.3% YoY). Sales on the other hand came in at Rs 7 bn (up 32.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 60.8% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 60.8% YoY). Sales on the other hand came in at Rs 7 bn (up 34.2% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (3QFY20); Net Profit Down 8.3% (Quarterly Result Update)

Jan 30, 2020 | Updated on Jan 30, 2020

For the quarter ended December 2019, TTK HEALTHCARE has posted a net profit of Rs 45 m (down 8.3% YoY). Sales on the other hand came in at Rs 2 bn (up 11.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

AJANTA PHARMA Announces Quarterly Results (2QFY20); Net Profit Down 7.2% (Quarterly Result Update)

Nov 8, 2019 | Updated on Nov 8, 2019

For the quarter ended September 2019, AJANTA PHARMA has posted a net profit of Rs 1 bn (down 7.2% YoY). Sales on the other hand came in at Rs 6 bn (up 18.1% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 53.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, TTK HEALTHCARE has posted a net profit of Rs 36 m (down 53.8% YoY). Sales on the other hand came in at Rs 2 bn (up 3.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

More Views on News

Most Popular

These 5 Smallcaps Deserve a Place in Your Coffee Can Portfolio(Profit Hunter)

Jul 28, 2020

When it comes to quality stocks, doing less is more.

Before You Buy Your First Electric Vehicle Consider Buying this Stock(Profit Hunter)

Jul 29, 2020

As competition intensifies in the electric vehicle space, only few will create huge wealth over the years.

Large Opportunities Are Coming Our Way

Aug 5, 2020

Kenneth Andrade tells us why stocks will bounce back strongly and what he's bullish on.

How to Buy Gold and Silver(Fast Profits Daily)

Jul 27, 2020

In this video I'll show you how to buy bullion the right way.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Aug 7, 2020 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE - SHASUN PHARMA COMPARISON

COMPARE TTK HEALTHCARE WITH

MARKET STATS